Market Overview

Top 4 Stocks In The Drug Delivery Industry With The Highest EPS Estimates For The Next Quarter

Related HSP
Hospira Granted Temporary Restraining Order Against FDA, Shares Pop Higher
BioScrip Posts Wider-than-Expected Q2 Loss on Poor Margins
Related PETS
PetMed Posts In Line Q1 Earnings, Revenues on Lower Orders
UPDATE: PetMed Express Posts In-Line Q1 Earnings

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.

Hospira (NYSE: HSP) is estimated to post earnings of $0.51 per share in the March quarter. Hospira's trailing-twelve-month revenue is $4.01 billion.

PetMed Express (NASDAQ: PETS) is expected to earn $0.19 per share in the March quarter. PetMed Express's PEG ratio is 2.96.

Alkermes plc (NASDAQ: ALKS) is likely to earn $0.16 per share in the March quarter. Alkermes had $199.45 million in total cash for the latest quarter.

Elan Corporation plc (NYSE: ELN) may earn $0.09 per share in the March quarter. Elan's trailing-twelve-month operating margin is 11.65%.

Posted-In: Drug Delivery Industry Highest EPS EstimatesTrading Ideas

 

Related Articles (ALKS + ELN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters